Form 4 for ORMP ORAMED PHARMACEUTICALS INC.
Accepted 2021-12-07 00:00:00 ET · period of report 2021-12-03 · accession 0001213900-21-063983 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-07 | 2021-12-03 | ORMP | KIDRON NADAV | Pres, CEO, Dir | G - Gift | — | -20.0K | 818.2K | -2% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-03 | G | D | 20,000 | — | 818,209 | D | — | — | (F1) This transaction represents a charitable donation effective December 3, 2021. This is not a market transaction, thus no price has been reported. No value was received for the donated shares. The Reporting Person is not affiliated with, and has no control over, the donee. |